Tilray Forges Alliance with Germany's 'gesund leben' and Alliance Healthcare, Boosting Pharmacy Access for Medical Cannabis
TLRY has more than doubled off its 52-week low of $3.507 on light trading volume (0.2× avg).
Summary
Tilray Brands, through its Tilray Medical and CC Pharma subsidiaries, has announced a strategic alliance with "gesund leben" cooperation and Alliance Healthcare Deutschland to significantly expand its market presence and pharmacy access across Germany. This partnership, effective April 1, 2026, leverages Alliance Healthcare Deutschland's network, which supplies over 10,000 pharmacies, and the "gesund leben" cooperation's 3,600 member pharmacies. The alliance will distribute Tilray Medical's cannabis portfolio, prescription medications, and parallel import medicines, substantially strengthening Tilray's integrated healthcare platform in a key European market. This move aligns with Tilray's reported robust international cannabis revenue growth from its last earnings report and provides a material boost to its distribution capabilities for both medical cannabis and pharmaceutical products. Traders should monitor the execution of this partnership and its impact on Tilray's international revenue growth in upcoming quarters.
At the time of this announcement, TLRY was trading at $7.21 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $841.2M. The 52-week trading range was $3.51 to $23.20. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.